Plasmanate Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The plasmanate market research report is one of a series of new reports that provides plasmanate market statistics, including the plasmanate industry's global market size, regional shares, competitors with a plasmanate market share, detailed plasmanate market segments, market trends and opportunities, and any further data you may need to thrive in the plasmanate industry. This plasmanate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising prevalence of chronic illnesses, rising prevalence of autoimmune diseases, expansion of plasma donation centers, growth of medical tourism, and rising incidence of mass casualty events. Major trends in the forecast period include artificial integration in plasma production, development of pathogen-free plasma solutions, advancements in plasma protein stabilization, blockchain in plasma supply chain management, and hybrid plasma solutions.

The growing number of trauma cases is expected to drive the demand for Plasmanate in the coming years. Trauma refers to serious injuries or psychological distress caused by external forces or traumatic events, often requiring urgent medical intervention, surgery, and rehabilitation. The rise in trauma cases is linked to factors such as increased accident rates, urbanization exposing people to more hazardous environments, and lifestyle changes such as greater risk-taking behaviors and substance abuse. Trauma patients, particularly those experiencing hypovolemic shock due to significant blood loss, may need plasma transfusions to restore blood volume and stabilize blood pressure. For instance, a report from Wolters Kluwer Health Inc. in June 2022 revealed that around 22,000 significant trauma cases occur annually in the UK, making trauma the leading cause of death for people under 45. This growing incidence of trauma is driving the demand for Plasmanate.

The rising prevalence of autoimmune diseases is another key factor expected to boost the growth of the Plasmanate market. Autoimmune diseases occur when the immune system mistakenly attacks the body’s healthy tissues, treating them as foreign invaders. The increasing prevalence of these conditions is influenced by factors such as better awareness and diagnosis, genetic factors, and environmental influences such as pollution, diet, and lifestyle. Plasmanate is often used in autoimmune diseases to restore plasma volume and stabilize the patient's condition during immune-mediated crises. For example, the National Health Service (NHS) in England reported in July 2024 that multiple sclerosis affects over 150,000 people in the UK, with new diagnoses occurring weekly. This growing prevalence of autoimmune diseases is contributing to the rising demand for Plasmanate.

The increasing number of chronic illnesses is expected to further expand the Plasmanate market. Chronic illnesses are long-term health conditions that typically require continuous medical care and can severely limit daily activities. Factors such as rising obesity rates, high blood pressure, unhealthy lifestyles, and aging populations contribute to the growing burden of chronic diseases. Plasmanate is often used in the management of chronic conditions such as liver disease, severe burns, and nephrotic syndrome to restore plasma volume and treat hypoproteinemia. For example, the Office for Health Improvement and Disparities reported in February 2024 that England saw 5,776 premature deaths due to alcoholic liver disease in 2022, indicating a slight increase from the previous year. This growing prevalence of chronic illnesses is driving the demand for Plasmanate in healthcare settings.

The key company operating in the plasmanate market is Grifols Therapeutics LLC.

North America was the largest region in the plasmanate market in 2024. The regions covered in plasmanate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plasmanate market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Plasmanate is a plasma protein fraction derived from human blood, primarily composed of albumin, and is used as a volume expander in medical settings. It is typically administered to treat hypovolemia (low blood volume) resulting from conditions such as surgery, trauma, or burns. Plasmanate is pasteurized to minimize the risk of viral transmission, ensuring its safety for use.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary formulations of Plasmanate include liquid and lyophilized formulations. Liquid formulations are ready-to-use and can be directly administered to patients, providing quick restoration of fluids and proteins. These are commonly used in emergency and hospital settings where immediate therapeutic effects are necessary. Clinical indications for Plasmanate include hypovolemia, burns, shock, hypoproteinemia, and surgical procedures. It is distributed through various channels such as online pharmacies and wholesale distributors, and is predominantly used by hospitals and clinical research laboratories.

The plasmanate market consists of sales of plasmanate 5% infusion, and plasmanate 5% injection 250ml. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.